In post-transplant conditions, sulfur may be protective by intermediate conversion to hydrogen sulfide and thiosulfate. However, sulfate, the end product of sulfur-containing amino acids (SAAs), contributes to metabolic acid load and may adversely influence acid-base homeostasis. We investigated the association of urinary sulfur metabolites with cardiometabolic parameters in renal transplant recipients (RTRs) and analyzed their predictive capacity for mortality. We studied urinary sulfate and thiosulfate excretion in 24-hour urine samples from 707 RTRs at a median 5.4 years (interquartile range, 1.9 to 12.2) after transplantation as well as from 110 controls. Diet was assessed for SAA content and various risk factors were measured. Urinary sulfate was similar, whereas thiosulfate was higher in RTRs versus controls. SAA intake was lower in RTRs compared with controls and correlated with sulfate but not thiosulfate excretion. Sulfate beneficially associated with eGFR, net acid excretion, systolic BP, high-sensitivity C-reactive protein, N-terminal probrain natriuretic peptide, and proteinuria (all P#0.01). Thiosulfate beneficially associated with eGFR, serum acidity, high-sensitivity C-reactive protein, and N-terminal probrain natriuretic peptide (all P#0.001). During a median 27 months (interquartile range, 22-36) of follow-up, 47 RTRs died. After adjustment for age, sex, and eGFR, hazard ratios for mortality were 0.87 (95% confidence interval, 0.82 to 0.92; P,0.001) for urinary sulfate and 0.60 (95% confidence interval, 0.41 to 0.59; P=0.01) for thiosulfate. Thus, despite the association of urinary sulfate with metabolic acid load, urinary sulfate and thiosulfate beneficially associated with survival in RTRs, possibly by influencing cardiovascular parameters. Intervention studies with exogenous sulfur are warranted to elucidate mechanisms underlying these promising associations in RTRs.
metabolic acid load appeared to be adversely associated with various cardiovascular and metabolic processes in RTRs. 5, 6 In the past decades, interest in sulfur metabolism in humans has grown considerably, particularly with regard to the synthesis and function of hydrogen sulfide (H 2 S). [7] [8] [9] [10] [11] [12] [13] [14] [15] H 2 S is an endogenously produced gaseous compound and a signaling molecule with substantial biologic potential, suggested to be beneficially involved in various (patho-)physiologic processes including BP regulation, inflammation, angiogenesis, and cytoprotection during hypoxia. [7] [8] [9] [10] [11] [12] [13] [14] [15] H 2 S is synthesized by conversion of the amino acid cysteine, which is either directly ingested via food or originates from the essential amino acid methionine. A specific intermediate of the H 2 S metabolism is thiosulfate (S 2 O 3 22 ), which is physiologically excreted in urine. Indeed, urinary thiosulfate has been reported to be linearly associated with inhaled or intravenously administered H 2 S, and might therefore, at least in part, reflect systemic H 2 S levels. 16 Because of the protective effects of H 2 S, it can be hypothesized that increasing intake of sulfur-containing amino acids (SAAs) contributes to the synthesis of H 2 S and beneficially influences the cardiovascular profile and, consequently, patient survival. On the other hand, the major end product of SAAs is sulfate (SO 4 22 ), 17, 18 which is allegedly adverse for its contribution to metabolic acid load and systemic acidosis, particularly in patients with impaired renal function. 6 Therefore, the roles of sulfur metabolism in cardiovascular and metabolic health in RTRs and whether sulfuric compounds should be considered beneficial or harmful are unclear.
We investigated the association of sulfur-containing metabolites with cardiovascular and metabolic parameters in a large, well defined cohort of stable RTRs. Intake of protein, particularly SAAs, and protein sources was assessed with food frequency questionnaires (FFQs). In RTRs and in healthy controls, we measured sulfate and thiosulfate and investigated the associations of these metabolites with cardiovascular and metabolic parameters in RTRs. In addition, we analyzed the association of urinary sulfate and thiosulfate excretion with mortality in RTRs.
RESULTS
The characteristics of RTRs and controls are shown in Table 1 . For RTRs, the median time between transplantation and baseline measurements was 5.4 years (interquartile range [IQR], 1.9-12.2). The two groups were similar with respect to age, body mass index (BMI), and body surface area (BSA). Men were overrepresented in the RTR group compared with the control group. Urinary sulfate excretion was similar in both groups (18. 065.6 in controls versus 17.666.4 in RTRs; P=0.29), but thiosulfate excretion was significantly higher in RTRs compared with controls (7.0 [IQR, 3.9-11.9] versus 2.1 [IQR, 0.29-10.1]; P,0.001). As anticipated, creatinine clearance was significantly lower in RTRs than in healthy participants (66626 versus 132641 ml/min; P,0.001). Correspondingly, higher BP values were observed in RTRs than in controls (systolic BP [SBP] , 136618 versus 125615 mmHg; diastolic BP [DBP] , 83611 versus 7569 mmHg; both P,0.001), despite 89% of RTRs using one or more antihypertensive drugs. Compared with controls, RTRs had significantly higher serum levels of triglycerides, glycosylated hemoglobin (HbA1c), high-sensitivity C-reactive protein (hs-CRP), and N-terminal probrain natriuretic peptide (NT-proBNP) (all P,0.001). Serum albumin levels, serum pH, and serum bicarbonate levels were lower and RTRs were more likely to have metabolic acidosis (blood HCO 3 2 ,24 mmol/L; P,0.001). Energy intake, as well as intake of total protein, plant protein, SAA, and total fat, was significantly lower in RTRs than in controls.
Patient characteristics according to sex-stratified tertiles of urinary sulfate and urinary thiosulfate excretion are shown in Supplemental Tables 1 and 2 . There were no differences across tertiles regarding preexisting disease, diabetes, and time since transplantation. The regression coefficients for the associations of urinary sulfate and thiosulfate with relevant cardiovascular parameters are presented in Table 2 . After adjustment for potential confounders (model 3), urinary sulfate excretion was significantly inversely associated with SBP (b=20.34; P=0.004), pulse pressure (b=20.33; P,0.001), serum NTproBNP (b=20.03; P,0.001), serum hs-CRP (b=20.04; P,0.001), serum HbA1c (b=20.02; P=0.01), and proteinuria (b=20.04; P=0.002). A direct association was observed between urinary sulfate excretion and eGFR (b=0.48; P,0.001). All observed associations remained significant after additional adjustment for urinary thiosulfate excretion. After adjustment for sulfate excretion (model 4), thiosulfate excretion was also significantly inversely associated with NT-proBNP (b=20.03; P,0.001) and hs-CRP (b=20.02; P,0.001). A direct association was observed between thiosulfate and eGFR (b=0.34; P,0.001). Associations of sulfate and thiosulfate with metabolic parameters are shown in Table 3 . Sulfate was positively associated with net acid excretion (NAE) (b=1.33; P,0.001), reflecting metabolic acid load, but no association was seen with serum HCO 3 2 (b=1.03; P=0.13) or serum pH (b=0.001; P=0.55). For thiosulfate, no association was observed with NAE; however, direct associations were observed with venous HCO 3 2 (b=0.03; P,0.001) and venous pH (b=0.01; P,0.001). Again, these associations remained significant after additional adjustment for urinary sulfate excretion. Figure 1 depicts the standardized b values of the associations of sulfur-containing metabolites with cardiovascular and metabolic parameters (model 3), allowing for mutual comparison of the strengths of associations.
The regression coefficients for the association of dietary protein and urinary sulfate and thiosulfate excretion are shown in Table 4 . After adjustment for age, sex, BSA, and renal function, significant positive associations were observed between urinary sulfate and intake of total protein (standardized b=0. 22 h; P=0.01) than RTRs who survived during follow-up. According to sex-stratified tertiles of sulfate, incidence of mortality during follow-up was 31 of 203 (15%) for the lowest tertile, whereas it was 10 of 226 (4%) and 6 of 229 (3%) in the middle and highest tertiles, respectively (log-rank test P,0.001; Figure 2A ). According to increasing sex-stratified tertiles of thiosulfate, these values were 22 (10%), 17 (7%), and 8 (3%), respectively (log-rank test P=0.02; Figure 2B ). Results of Cox regression analyses for mortality in RTRs are shown in lowest tertile as reference category), the hazard ratios of the highest tertiles of urinary sulfate and urinary thiosulfate excretion were 0.20 (95% CI, 0.08 to 0.49; P,0.001) and 0.30 (95% CI, 0.12 to 0.78; P=0.01), respectively, after adjustment for age, sex, and renal function (model 3). Slight but significant differences were observed regarding several factors that might be considered confounders of the association between urinary sulfate or thiosulfate excretion and mortality in RTRs. These include BMI, proteinuria, use of immunosuppressive agents, and use of antihypertensive medication. However, secondary Cox regression analyses with additional adjustment for these factors did not materially change our findings (Table 5) .
DISCUSSION
The cardinal finding of this study is the significant association of urinary sulfur metabolites with a favorable cardiovascular risk profile and with improved survival in RTRs. These associations were found despite the observed direct association of urinary sulfate with the allegedly adverse metabolic acid load. In addition, RTRs had a markedly elevated excretion of urinary thiosulfate, but not sulfate, compared with healthy controls. Our findings suggest a protective role for sulfur metabolites in cardiovascular changes after renal transplantation and in long-term patient survival after transplantation.
Humans depend on exogenous sources for their sulfur supplies because sulfur enters the body mainly as a constituent of the SAAs cysteine and methionine. In line with previous studies, we observed a significant direct association between intake of SAAs and urinary sulfate excretion. 17, 18 SAAs are eventually converted to sulfate and are allegedly adverse for their contribution to metabolic acid load, which has previously been shown to be associated with the extent of acidosis in RTRs. 6 In accordance, a significant association between intake of SAAs and NAE was found, the latter reflecting metabolic acid load. 19 Nevertheless, regarding systemic metabolic parameters, we observed no significant association of sulfate with blood pH and , which could suggest a favorable role for thiosulfate in acid-base homeostasis, given the large body of RTRs experiencing systemic acidosis. 6 The significance of and mechanism underlying this association are not yet clear and need further elucidation.
Regarding cardiovascular parameters, we observed beneficial associations of thiosulfate with NT-proBNP, hs-CRP, and eGFR. Because thiosulfate is a central metabolite in the metabolic pathway of H 2 S, a gaseous transmitter known for its protective role in several pathologic processes such as inflammation and hypertension, a potential explanation for our findings might be involvement of H 2 S. H 2 S is synthesized endogenously by the activity of three major enzymes, cystathionine-b-synthetase (CBS), cystathionine-g-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase, which all use the amino acid L-cysteine as their main substrate. 20 CSE, the most predominant enzyme in cardiovascular tissue, is expressed in endothelial and smooth muscle cells. In the vasculature, H 2 S is known to function as an endothelial cell-relaxing factor. Accordingly, CSE 2/2 mice have a slightly higher BP than wild-type mice. 21 Endothelial-derived H 2 S also functions as a promoter of angiogenesis and as an inhibitor of leukocyte adhesion, thereby reducing inflammation. 7, 13 Tokuda et al. recently reported that inhalation of H 2 S prevented endotoxin-induced systemic inflammation and even prolonged survival in endotoxemic mice. 22 H 2 S eventually gets degraded to thiosulfate, which is partly reused as a sulfur donor to form a new H 2 S molecule, partly converted to sulfite, the latter being oxidized to sulfate and physiologically excreted in the urine. A certain amount of thiosulfate, however, is excreted directly in the urine, possibly as "spillover" of H 2 S synthesis and might therefore at least in part reflect systemic levels of H 2 S. 23 Another potential explanation for our findings might be that thiosulfate itself underlies the favorable associations with cardiovascular parameters in RTRs. Thiosulfate has been reported to exert protective activities in several pathophysiologic processes such as oxidative stress. 24 In addition, thiosulfate has recently been shown to completely prevent vascular calcifications in uremic rats. 25 Moreover, thiosulfate can be safely administered to humans and is well tolerated. 26 Unexpectedly, similar beneficial associations were observed for sulfate, with even additional favorable associations with SBP, pulse pressure, HbA1c, and proteinuria. This was in contrast with our hypothesis that urinary sulfate, reflecting intake of acidifying SAA and metabolic acid load, contributes to systemic acidosis and related complications such as hypertension and insulin resistance, particularly in patients with impaired renal function. 6 An explanation might be that part of the excreted sulfate has been incorporated in the H 2 S and/or thiosulfate synthesis as well, which is in line with previous studies showing that systemically applied H 2 S is excreted as either thiosulfate or sulfate. 23, 27 This could also explain our findings of survival benefit in RTRs with either higher urinary sulfate or higher thiosulfate excretion.
In our study, unlike sulfate, thiosulfate was not associated with dietary sulfur intake. Although the synthesis of H 2 S, and consequently thiosulfate, depends on the intake of SAAs, particularly methionine, the rate-limiting step is the presence of specific enzymes such as CBS and CSE. The absence of any association of thiosulfate with dietary intake could be explained by an excess presence of SAAs. We observed significantly higher urinary excretion of thiosulfate in RTRs compared with healthy controls. This was quite surprising because it might be expected that RTRs, known to be at high cardiovascular risk compared with the general population, excrete less of an indicator of the allegedly favorable H 2 S metabolism. It seems unlikely that differences in dietary protein intake between both groups underlie the differences in urinary thiosulfate excretion, because intake was lower in RTRs compared with controls. Possibly, the higher urinary thiosulfate excretion reflects a compensatory response to meet the increased demand for cardiovascular protection in RTRs. It could also be that prednisolone treatment in RTRs explains the difference, because it is known that glucocorticoids induce CBS activity in the liver. 28 Little is known regarding renal handling of sulfate and thiosulfate. Regarding thiosulfate, Newman et al. reported that the clearance rates of inulin and thiosulfate are nearly identical. 29 In the proximal tubulus, there seems to be some tubular handling, both secretion and reabsorption, as evidenced from studies in rats, rabbits, cats, and dogs. [30] [31] [32] Sulfate is freely filtered in the glomerulus, and approximately 80% is reabsorbed in the proximal tubules. 33 It is known that at least two transporters are involved in this process (NaSi-1 and Sat-1). Both of these transporters can also transport thiosulfate. 34 A finding that puzzled us was the observation that a single transplanted kidney seems to excrete more thiosulfate than two normal kidneys do. An explanation might be that two normal kidneys can more completely perform proximal tubular reabsorption of filtered thiosulfate than one transplanted kidney. Another possibility is that a certain degree of renal insufficiency in one way or another leads to a compensatory increase in endogenous thiosulfate synthesis and subsequent excretion of it. However, to date, there are no data available to support or disprove either of these lines of reasoning or both.
Strengths of our study include the large sample size of this specific patient group consisting of well defined, stable RTRs. Extensive data collection, including data from 24-hour urine samples and dietary intake, allowed for adjustment for many confounders. We acknowledge, however, that there are also limitations. This study is an observational epidemiologic study, which makes it difficult to draw conclusions on causality. In general, statistical significance in observational studies suggests, but does not confirm, biologic significance. Whether the significant relation between urinary sulfate and thiosulfate and mortality in RTRs is a causal or an associative relation remains to be determined. In addition, it is not known whether thiosulfate excretion truly represents increased H 2 S production. However, it has repeatedly been shown that urinary thiosulfate excretion increases during H 2 S inhalation. 16, 35 Because little is known regarding the role of sulfur in cardiovascular health in RTRs and the sulfur handling in the kidney, a third factor might underlie the observed associations. For example, it can be hypothesized that higher urinary excretion of sulfur compounds is caused by decreased tubular reabsorption due to renal damage, which itself is well known to be associated with cardiovascular risk. However, the association between urinary sulfur metabolites and cardiovascular parameters remained significant in multivariate regression analyses, including renal function, suggesting that this association is independent of confounding factors. Nevertheless, residual confounding could have remained, because it is hard to completely adjust for the severity of each risk factor. In addition, our study population consisted predominantly of Caucasian individuals, which calls prudence to extrapolation of our results to populations of other ethnicities. The detailed metabolic determinants influencing urinary excretions of both sulfate and thiosulfate are not clear thus far and require further elucidation. Additional studies could focus on the H 2 S and thiosulfate metabolism and the involved enzymes, to reveal the mechanism underlying the observed associations and to investigate the potentially beneficial effects of sulfur suppletion.
Post-transplant conditions are associated with markedly increased risk for cardiovascular diseases compared with healthy individuals. The observed beneficial associations of urinary sulfur metabolites with cardiovascular parameters and patient survival in our transplant cohort might point toward a protective role of components in the sulfur metabolism. Longterm intervention studies with exogenous sulfur, either from the diet or pharmacologic agents such as sodium thiosulfate, are warranted to clarify the exact role and underlying mechanisms of sulfur metabolism in cardiovascular health and survival in RTRs.
CONCISE METHODS

Study Population
All RTRs (aged$18 years) with a functioning graft for at least 1 year who visited our outpatient clinic between 2008 and 2010 were invited to participate in this study. RTRs were all transplanted at the University Medical Center Groningen and had no history of drug or alcohol addiction. Of 817 initially invited RTRs, 707 (87%) signed written informed consent to participate in this study. As a reference group, we included 110 participants who were evaluated and approved for living kidney donation in our center. None had a history of kidney disease, diabetes, or cardiovascular events. Hypertension, if present, was treated with a maximum of one antihypertensive drug. For analyses regarding dietary intake, we excluded patients with missing dietary data, resulting in 637 RTRs eligible for analyses. Our institutional review board approved the study protocol (METc 2008/186), which adhered to the Declaration of Helsinki.
Assessment of Dietary Intake
Dietary intake was assessed with a validated semiquantitative FFQ that was developed at Wageningen University 36 and updated several times. For our study, the FFQ was slightly modified for accurate assessment of protein intake, including types and sources of protein. Validity of the FFQ in RTRs was assessed as previously described. 37 The FFQ inquired about intake of 177 food items during the last month, taking seasonal variations into account. For each item, the frequency was recorded in times per day, week, or month. The number of servings was expressed in natural units (e.g., slice of bread or apple) or household measures (e.g., cup or spoon). The questionnaire was selfadministered and filled out at home. All FFQs were checked for completeness by a trained researcher and inconsistent answers were verified with the patients. Dietary data were converted into daily nutrient intake using the Dutch Food Composition 
Urine and Plasma Parameters
All participants were instructed to collect a 24-hour urine sample according to a strict protocol at the day before their visit to the outpatient clinic. Urine was collected under oil and chlorhexidine was added as an antiseptic agent. Urinary sulfate was measured chromatographically (type 861; Metrohm, Herisau, Switzerland). Intraand inter-assay variations were 2.0% and 4.3%, respectively. Urinary thiosulfate was determined by a specific HPLC method as previously described. 26, 39 Briefly, 25 ml of urine was derivatized with 5 ml of 46 mM monobromobimane, 25 ml of acetonitrile, and 25 ml of 160 mM Blood was drawn in the morning after completion of the 24-hour urine collection. Venous blood gas analyses were assessed photometrically immediately after collection of blood samples. Plasma and urinary concentrations of electrolytes, phosphate, albumin, and urea were measured using routine laboratory methods, as were serum cholesterol, HbA1c, hs-CRP, and NT-proBNP levels. Serum creatinine was determined using a modified version of the Jaffé method (MEGA AU 510; Merck Diagnostica, Darmstadt, Germany). Renal function was assessed by estimating GFR applying the Chronic Kidney Disease Epidemiology Collaboration equation. 40 Urinary albumin concentration was determined by nephelometry (Dade Behring Diagnostic, Marburg, Germany). Total urinary protein concentration was analyzed using the Biuret reaction (MEGA AU 510; Merck Diagnostica). Proteinuria was defined as urinary protein excretion $0.5 g/24 h.
Clinical Parameters
All measurements were performed during a morning visit to the outpatient clinic after an 8-to 12-hour overnight fasting period. BP was measured (in millimeters of mercury) according to a strict protocol as previously described. 5 Participants were left alone in a room in half-sitting position while SBP, DBP, mean arterial pressure, and heart rate were measured with a semiautomatic device (Dinamap 1846; Critikon, Tampa, FL). Measurements were performed every minute for 15 minutes and the last three values were averaged. Information on participants' health status, medical history, and medication use was obtained from patient records. Information on smoking behavior was obtained by using a questionnaire. Participants were classified as current, former, or never smokers. Body weight and height were measured with participants wearing indoor clothing without shoes. BMI was calculated as weight in kilograms divided by height in meters squared and BSA was estimated applying the universally adopted formula of Du Bois and Du Bois. 41 Diabetes was defined as use of antidiabetic medication or fasting plasma glucose$7.0 mmol/L according to American Diabetes Association criteria as previously described by our group. 42 
Statistical Analyses
Data analysis was performed using SPSS 18.0 software (SPSS, Inc., Chicago, IL). Normality was tested with the Kolmogorov-Smirnov test and skewed data were normalized for analyses by logarithmic transformation (albuminuria, thiosulfate excretion, hs-CRP, NTproBNP, and protein excretion). Data are presented as the mean6SD, unless stated otherwise. Differences between RTRs and healthy controls were tested with the t test for independent samples, the MannWhitney U test, or the chi-squared test. The associations of sulfate and thiosulfate excretion with various potentially relevant cardiovascular factors were analyzed with linear regression analysis, with adjustment for age, sex, and BSA (model 1) and cumulative additional adjustments for eGFR (model 2) and urinary sodium excretion and use of medication (antihypertensives, calcineurin inhibitors, proliferation inhibitors; model 3). Cardiovascular factors were considered potentially relevant if the P value for association in sexstratified analyses was ,0.10 (see Supplemental Tables 1 and 2 ). To study the potential interdependence of both sulfur metabolites, we also adjusted for either thiosulfate or sulfate (model 4). The association of dietary intake with urinary sulfur metabolites was investigated with linear regression analyses adjusting for age and sex (model 1), BSA (model 2), and eGFR (model 3). Regression coefficients are given as b or standardized b values, the latter referring to the number of SDs a dependent variable changes, per SD increase of the independent variable (either sulfate or thiosulfate), allowing for comparison of the strength of the associations. In prospective analyses, we investigated associations of urinary sulfate and thiosulfate excretion with mortality in RTRs. We performed crude Cox regression analyses (model 1) and analyses with adjustment for age, sex (model 2), and renal function (model 3). Although the rule of thumb that no more than one potentially explanatory variable can be included in Cox regression analyses for each outcome 10 events has been debated, 43 it is obvious that because of the limited number of outcome events in our study, not all variables that differed significantly between sex-stratified tertiles of urinary sulfate and urinary thiosulfate excretion can be included in one model. Therefore, in further models (models 4-6), we additionally adjusted model 3 for potential confounders, which were selected on the basis of a P value ,0.10 in sex-stratified analyses (see Supplemental Tables 1 and 2 ).
Other variables that could lie in the causal pathway of urinary sulfate and urinary thiosulfate excretion with outcome were not adjusted for, because this could unintentionally obscure otherwise existing associations. 44 In all analyses, a two-sided P value ,0.05 was considered statistically significant.
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